Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of ...

The glucagon-like peptides (GLP-1 and GLP-2) are processed from the proglucagon polypeptide and secreted in equimolar amounts but have opposite effects on chylomicron (CM) production, with GLP-1 ...

“In the brain, GLP-1 receptors act like a stop light and tell certain areas of the brain to stop releasing dopamine, the feel-good chemical that reinforces compulsive or addictive ...

Since GLP-1 agonists soared in popularity thanks to their powerful ... Science History Institute invites monthly speakers who are leaders from a wide variety of chemical and life science companies to ...